Proximagen has a strong track record of collaborations and our commitment to partnerships continues
Our strategy for collaborations is to both “partner-in” and “partner-out”. We apply our drug discovery and development expertise to build value in programs and then seek partners for later stage development and commercialisation.
- We are interested in preclinical small molecule programs against novel targets to feed our pipeline of programs to move into development
- We are open to discussions on our more advanced programs with partners for later stage development and commercialization